『The Ozempic and GLP-1 shockwave hitting U.S. dairy』のカバーアート

The Ozempic and GLP-1 shockwave hitting U.S. dairy

The Ozempic and GLP-1 shockwave hitting U.S. dairy

無料で聴く

ポッドキャストの詳細を見る

このコンテンツについて

 GLP-1s like Ozempic and Wegovy are changing how Americans eat, and that has big implications for the dairy industry. In this episode of The Milk Check, host Ted Jacoby III welcomes Paul Ziemnisky, leader of nutrition and industry growth platforms at Dairy Management Inc., and Dr. Chris Cifelli, vice president of nutrition research for the National Dairy Council. Together with the Jacoby team, they unpack what GLP-1 appetite-suppressing drugs mean for dairy demand, and how our industry can win. We cover: How GLP-1s suppress hunger and how dairy’s fat + protein combo supports satiety How protein quality matters more than ever, and why dairy still leads the pack How R&D teams are turning classic dairy products into high-protein, low-sugar solutions From gut health to GLP-1 support, this episode dives deep into one of the most important trends shaping dairy today. Join us for The Milk Check episode 81: The Ozempic and GLP-1 shockwave hitting U.S. dairy. Intro with music: Welcome to the Milk Check, a podcast from T.C. Jacoby & Co, where we share market insights and analysis with dairy farmers in mind. Ted Jacoby III: Hello, everybody, and welcome to the Milk Check. Excited to be here today. In addition to our usual suspects, Josh White, Mike Brown, and my brother guest, Jacoby. We've got two special guests today. We have Paul Ziemnisky, leader for nutrition and product science, technology, innovation and industry growth platforms at Dairy Management Inc. Again, we have Dr. Chris Cifelli, vice president of nutrition research for the National Dairy Council. Guys, thank you so much for joining us today. Thank you for taking time out of your busy days to talk about GLP-1s and how it's affecting the dairy industry. We really appreciate it. What are GLP-1s and why are they good for dairy? Dr. Chris Cifelli: I'll start with what they are and then Paul can talk about the consumer point of view. One of the key things whenever we eat food is that feeling of satiety, the feeling of fullness we get during a meal and then the satiation that occurs between meals until we get those body cues again that we're hungry and we want to eat. Unfortunately, in the environment we're in with stress and different factors, our body is a lot off schedule, so we tend to eat a lot more than we may need to on a daily basis. What GLP's are, glucagon like peptide is the official name, it's an appetite suppressant. So, when you eat and especially when you eat fat and protein, the body will release GLP-1 naturally, and that's what starts making you feel full. What these pharmaceuticals are, are ways to keep the levels of GLP-1 up in your body so you feel less hungry throughout the day more naturally. And what that's going to do is you're not going to snack quite as much. You're not going to have those cravings maybe for sweet salty snacks during the day. But with that appetite suppressant, it means that every calorie really then matters when you're eating throughout the day, and that's really where dairy can win. Paul Ziemnisky: To build on that, what it means for dairy is, I think Chris used two magic words, fat and protein. I think fat's been vilified since this early '70s, late '60s, and we've put a lot of effort in investment in proving the value of fat, especially dairy fats. I think you're going to see in the next six months, the acceleration of an acceptance of fat into things like the dietary guidelines and other uses. And the protein side of the equation, we've got the highest quality protein by far. We've got science behind the highest quality proteins and the efficacy of that. And then by the way, consumers, when they purchase anything, taste is number one factor. So, when you look at taste, price, value, health and wellness, we deliver on all those three sweet spots for that consumer. And so, you see things like yogurt on fire because of that,
まだレビューはありません